Smith & Nephew PLC (SN.L) Key Developments | Reuters.com
Edition:
United States

Smith & Nephew PLC (SN.L)

SN.L on London Stock Exchange

1,282.00GBp
1 Jul 2016
Change (% chg)

15.00p (+1.18%)
Prev Close
1,267.00p
Open
1,275.00p
Day's High
1,293.00p
Day's Low
1,266.00p
Volume
4,375,796
Avg. Vol
2,182,429
52-wk High
1,293.00p
52-wk Low
1,040.36p

Latest Key Developments (Source: Significant Developments)

Smith & Nephew sells gynaecology unit to Medtronic
Wednesday, 18 May 2016 08:00am EDT 

Smith & Nephew Plc : Divestment and share buy-back . Signed a definitive agreement to divest its gynaecology business to Medtronic Plc (NYSE:MDT) for $350 million. . Gynaecology delivered revenue of $56 million in 2015, representing a little over 1% of group revenue. . Transaction is expected to be broadly neutral to adjusted earnings ('EPSA') in 2017, after share buy-back, . Share buy back is expected to commence shortly after completion in July 2016 . Proceeds will be returned to shareholders through a $300 million share buy-back programme. . Gross proceeds are before tax and costs. . Is expected that majority of gynaecology employees will join Medtronic . Davis Polk & Wardwell Llp served as counsel to Smith & Nephew and Ondra Partners acted as financial advisor. .Divestment and share buy-back.  Full Article

Smith & Nephew Plc acquires first-line cartilage repair product
Tuesday, 12 Jan 2016 08:00am EST 

Smith & Nephew Plc:Acquires first-line cartilage repair product.Terms of the transaction were not disclosed.  Full Article

Smith & Nephew plc completes acquisition of Blue Belt Holdings Inc
Tuesday, 5 Jan 2016 02:00am EST 

Smith & Nephew plc:Says it has completed the acquisition of Blue Belt Holdings, Inc.  Full Article

Smith & Nephew plc acquires Blue Belt Technologies
Thursday, 29 Oct 2015 03:00am EDT 

Smith & Nephew plc:Says that it has agreed to acquire Blue Belt Holdings, Inc. for $275 million.  Full Article

Smith & Nephew plc reaffirms FY 2015 guidance; declares interim dividend
Thursday, 30 Jul 2015 02:02am EDT 

Smith & Nephew plc:Says that outlook for FY 2015 remains unchanged.Says that it continue to expect to deliver higher underlying revenue growth in FY 2015 than in FY 2014.Says interim dividend for the H1 2015 is 11.8¢ per share (23.6¢ per ADS), compared with 11.0¢ last year.The interim dividend will be paid on Oct. 27 to shareholders on the register at the close of business on Oct. 9.  Full Article

Biotec Pharmacon ends discussion about Woulgan distribution agreement with Smith & Nephew
Tuesday, 7 Jul 2015 04:20am EDT 

Biotec Pharmacon ASA:Biotec Pharmacon ASA and Smith & Nephew have mutually decided to end the discussion about a Woulgan distribution agreement.  Full Article

Smith & Nephew PLC to acquire Zimmer's Unicondylar Knee system in US market
Wednesday, 24 Jun 2015 11:51am EDT 

Smith & Nephew PLC:Says it acquires Zimmer Unicompartmental High Flex Knee system in the US market.Says terms of the transaction were not disclosed.Has purchased all existing inventory and certain intellectual property for the US market.Transaction will close within three business days after the merger between Zimmer and Biomet has closed.  Full Article

Smith & Nephew PLC receives $99 mln patent infringement payment from Arthrex
Wednesday, 17 Jun 2015 08:00am EDT 

Smith & Nephew PLC:Has received payment in connection with recent affirmation by U.S. Court of Appeals for Federal Circuit of $95 mln patent infringement judgment against Arthrex, Inc., (Naples, Fla).  Full Article

Smith & Nephew acquires interactive software technology to drive supply chain optimisation and improve savings for Syncera(tm) customers
Wednesday, 6 May 2015 08:00am EDT 

Smith & Nephew PLC:Says the acquisition of two software assets from S2 Interactive, a surgical software development company.Software applications acquired by Smith & Nephew are Virtual Backtable (VBT) and TrayTouch.Terms of the transaction were not disclosed.  Full Article

Smith & Nephew plc reaffirms FY 2015 outlook
Thursday, 30 Apr 2015 02:00am EDT 

Smith & Nephew plc:Says that outlook for FY 2015 remains unchanged.Says that it continue to expect to deliver higher underlying revenue growth in FY 2015 than in FY 2014.  Full Article

Medical device maker Medtronic to buy HeartWare for $1.1 billion

Medtronic Plc said it would buy HeartWare International Inc for about $1.1 billion, bulking up its portfolio of devices for treating heart diseases and pushing deeper into the market for less-invasive surgical products.